Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
37 studies found for:    Open Studies | "Acromegaly"
Show Display Options
Rank Status Study
1 Unknown  Lanreotide Levels in Acromegaly
Condition: Acromegaly
Intervention: Other: Blood draw
2 Recruiting The Treatment and Natural History of Acromegaly
Conditions: Acromegaly;   Pituitary Neoplasm
Intervention:
3 Recruiting Epidemiology of Acromegaly
Condition: Acromegaly
Intervention:
4 Recruiting Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target
Condition: Acromegaly
Intervention: Drug: Sandostatin® LAR
5 Recruiting Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects
Conditions: Acromegaly;   Somatostatin;   Metabolism;   Signal Transduction
Intervention: Drug: GH
6 Recruiting Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?
Condition: Acromegaly
Intervention:
7 Recruiting A Prospective Study of Outcome After Therapy for Acromegaly
Condition: Acromegaly
Intervention:
8 Unknown  Ultrasound Guided Sandostatin LAR Injection in Acromegaly
Condition: Acromegaly
Intervention: Drug: Sandostatin LAR
9 Recruiting Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
Condition: Acromegaly
Intervention:
10 Available An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Pasireotide long acting release formulation
11 Recruiting Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
Conditions: Cushing's Disease,;   Acromegaly
Interventions: Drug: Pasireotide s.c.;   Drug: Sitagliptin;   Drug: Liraglutide;   Drug: Insulin;   Drug: Pasireotide LAR;   Drug: Metformin
12 Unknown  A Study Examining the Peri- and Post-operative Dynamics of the Growth Hormone (GH) - IGF-1 Axis in Subjects With Acromegaly During the First Year After Surgical Resection
Condition: Acromegaly
Intervention: Other: OGTT
13 Unknown  Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
Conditions: Acromegaly;   Heart Failure;   Hypertrophy, Left Ventricular
Intervention: Drug: pegvisomant
14 Not yet recruiting Late Effects of Radiosurgery on Acromegaly Study
Condition: Acromegaly
Intervention: Device: Gamma Knife radiosurgery
15 Recruiting Programme of Acromegaly Screening in Patients With Associated Somatic Disorders
Condition: Acromegaly
Intervention: Other: Non-interventional cross-sectional survey
16 Recruiting Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly
Condition: Acromegaly
Intervention:
17 Unknown  Prospective Study on Changes in Acromegaly
Condition: Acromegaly
Intervention:
18 Recruiting Somatuline Predictive Factors in Acromegaly and NET
Conditions: Acromegaly;   Neuroendocrine Tumours
Intervention: Drug: Somatuline Autogel® 60, 90 or 120 mg
19 Recruiting IGF-I and Free Fatty Acids Isn Glucose Metabolism in Acromegaly
Condition: Acromegaly
Intervention:
20 Recruiting Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations in Acromegaly
Condition: Acromegaly
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Indicates status has not been verified in more than two years